ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Total liabilities 2020–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) total liabilities at each fiscal year-end, per SEC filings.
$243.5MFY2025 · since FY2020: $27.6M → $243.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $243.5M | +27.3% |
| FY2024 | $191.3M | -24.3% |
| FY2023 | $252.7M | +5.4% |
| FY2022 | $239.7M | +117.0% |
| FY2021 | $110.5M | +299.6% |
| FY2020 | $27.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice